These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 25836013)
1. Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma. Kadota K; Yeh YC; Villena-Vargas J; Cherkassky L; Drill EN; Sima CS; Jones DR; Travis WD; Adusumilli PS Chest; 2015 Sep; 148(3):711-721. PubMed ID: 25836013 [TBL] [Abstract][Full Text] [Related]
2. Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. Suzuki K; Kadota K; Sima CS; Nitadori J; Rusch VW; Travis WD; Sadelain M; Adusumilli PS J Clin Oncol; 2013 Feb; 31(4):490-8. PubMed ID: 23269987 [TBL] [Abstract][Full Text] [Related]
3. FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-III. Jiang M; Wu C; Zhang L; Sun C; Wang H; Xu Y; Sun H; Zhu J; Zhao W; Fang Q; Yu J; Chen P; Wu S; Zheng Z; He Y; Zhou C J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34006632 [TBL] [Abstract][Full Text] [Related]
4. Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration. Kadota K; Eguchi T; Villena-Vargas J; Woo KM; Sima CS; Jones DR; Travis WD; Adusumilli PS Oncotarget; 2015 Sep; 6(29):27505-18. PubMed ID: 26318038 [TBL] [Abstract][Full Text] [Related]
5. Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma. Kim SW; Kim YI; Mustafa B; Kim MJ; Jeong G; Ahn SM; Lim SB; Yu CS; Kim JC; Hong SM; Park IJ Mod Pathol; 2021 Jan; 34(1):141-160. PubMed ID: 32709987 [TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer. Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453 [TBL] [Abstract][Full Text] [Related]
7. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma. Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145 [TBL] [Abstract][Full Text] [Related]
8. Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness. Yamaguchi Y; Ishii G; Kojima M; Yoh K; Otsuka H; Otaki Y; Aokage K; Yanagi S; Nagai K; Nishiwaki Y; Ochiai A J Thorac Oncol; 2010 Sep; 5(9):1361-8. PubMed ID: 20631633 [TBL] [Abstract][Full Text] [Related]
9. Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma. Kadota K; Buitrago D; Lee MC; Villena-Vargas J; Sima CS; Jones DR; Travis WD; Adusumilli PS Lung Cancer; 2015 Sep; 89(3):329-36. PubMed ID: 26141216 [TBL] [Abstract][Full Text] [Related]
10. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors. Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251 [TBL] [Abstract][Full Text] [Related]
11. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer. Kwak Y; Koh J; Kim DW; Kang SB; Kim WH; Lee HS Oncotarget; 2016 Dec; 7(49):81778-81790. PubMed ID: 27835889 [TBL] [Abstract][Full Text] [Related]
12. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239 [TBL] [Abstract][Full Text] [Related]
13. A study of the immune infiltrate and patient outcomes in esophageal cancer. Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666 [TBL] [Abstract][Full Text] [Related]
14. Relationships between tumor microenvironment and clinicopathological parameters in meningioma. Ding Y; Qiu L; Xu Q; Song L; Yang S; Yang T Int J Clin Exp Pathol; 2014; 7(10):6973-9. PubMed ID: 25400783 [TBL] [Abstract][Full Text] [Related]
15. Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival. Pocha K; Mock A; Rapp C; Dettling S; Warta R; Geisenberger C; Jungk C; Martins LR; Grabe N; Reuss D; Debus J; von Deimling A; Abdollahi A; Unterberg A; Herold-Mende CC Clin Cancer Res; 2020 May; 26(9):2231-2243. PubMed ID: 31953311 [TBL] [Abstract][Full Text] [Related]